Vertex Pharmaceuticals Inc (VRTX)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$488.60
Buy
$509.40
$4.61 (+0.94%)
Prices updated at 13 Nov 2024, 23:06 EST
| Prices minimum 15 mins delay
Prices in USD
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 87.21 |
| 2022 | 87.90 |
| 2021 | 88.06 |
| 2020 | 88.14 |
| 2019 | 86.84 |
| 2018 | 86.56 |
| 2017 | 88.95 |
| 2016 | 87.64 |
| 2015 | 87.94 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2024 | 11.93 |
| 2023 | 10.97 |
| 2022 | 8.57 |
| 2021 | 8.04 |
| 2020 | 10.40 |
| 2019 | 15.73 |
| 2018 | 15.13 |
| 2017 | 16.34 |
| 2016 | 10.83 |
| 2015 | 39.83 |
| 2014 | 35.25 |
Price/Forward earnings (YTD)
26.67
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | 17.71 |
| 2022 | 21.04 |
| 2021 | 18.60 |
| 2020 | 27.02 |
| 2019 | 16.16 |
| 2018 | 42.82 |
| 2017 | 8.17 |
| 2016 | -4.15 |
| 2015 | -23.02 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 1.29 |
| 2022 | 1.30 |
| 2021 | 1.33 |
| 2020 | 1.35 |
| 2019 | 1.37 |
| 2018 | 1.41 |
| 2017 | 1.75 |
| 2016 | 2.50 |
| 2015 | 2.66 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
